Zhi-jun Zhu
Clinical trials sponsored by Zhi-jun Zhu, explained in plain language.
-
Smaller liver grafts could revolutionize transplant safety
Disease control ENROLLING_BY_INVITATIONThis study looks at a new way to do liver transplants for people with severe portal hypertension. Instead of using a full-sized liver, doctors will use a smaller piece (small-for-size graft) in an auxiliary transplant, leaving part of the original liver in place. The goal is to s…
Sponsor: Zhi-Jun Zhu • Aim: Disease control
Last updated Jun 27, 2026 12:35 UTC
-
Liver transplants without blood type matching: a new hope?
Disease control ENROLLING_BY_INVITATIONThis study follows 100 people who received a liver transplant from a living donor with a different blood type. Researchers will track how long patients survive and how often their body rejects the new liver. The goal is to understand risks and improve care for these transplants.
Sponsor: Zhi-Jun Zhu • Aim: Disease control
Last updated Jun 27, 2026 12:35 UTC
-
Stem cell injection aims to prevent deadly liver complication
Disease control ENROLLING_BY_INVITATIONThis early-phase trial tests whether injecting special liver-like cells into the abdominal muscle can help prevent or treat Small-for-Size syndrome, a serious complication that can occur after partial liver surgery. The study involves 12 patients and focuses mainly on safety, che…
Phase: EARLY_PHASE1 • Sponsor: Zhi-Jun Zhu • Aim: Disease control
Last updated Jun 27, 2026 12:07 UTC